切换至 "中华医学电子期刊资源库"

中华普外科手术学杂志(电子版) ›› 2021, Vol. 15 ›› Issue (02) : 203 -206. doi: 10.3877/cma.j.issn.1674-3946.2021.02.023

所属专题: 文献

论著

逆向腋淋巴显影技术在乳腺癌患者中的临床运用及上肢回流淋巴结的分布与转移特点分析
毛婷1,(), 王越2, 李倩雯1, 吕淑贞1   
  1. 1. 100038 海淀,首都医科大学附属北京世纪坛医院乳腺外科
    2. 150010 哈尔滨,哈尔滨医科大学附属肿瘤医院乳腺放疗
  • 收稿日期:2020-05-18 出版日期:2021-04-26
  • 通信作者: 毛婷

The clinical application of reverse axillary lymphography for patients with breast cancer and the analysis of the distribution and metastasis characteristics of upper extremity lymph nodes

Ting Mao1,(), Yue Wang2, Qianwen Li1, Shuzhen Lyv1   

  1. 1. Department of Breast Surgery, Beijing Shijitan Hospital, Capital Medical University, Beijing 100038, China
    2. Department of Breast Radiotherapy, Cancer Hospital Affiliated to Harbin Medical University, Heilongjiang 150010, China
  • Received:2020-05-18 Published:2021-04-26
  • Corresponding author: Ting Mao
  • Supported by:
    Natural Science Foundation of Beijing City(7138126)
引用本文:

毛婷, 王越, 李倩雯, 吕淑贞. 逆向腋淋巴显影技术在乳腺癌患者中的临床运用及上肢回流淋巴结的分布与转移特点分析[J]. 中华普外科手术学杂志(电子版), 2021, 15(02): 203-206.

Ting Mao, Yue Wang, Qianwen Li, Shuzhen Lyv. The clinical application of reverse axillary lymphography for patients with breast cancer and the analysis of the distribution and metastasis characteristics of upper extremity lymph nodes[J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2021, 15(02): 203-206.

目的

研究逆向腋淋巴显影技术(ARM)在乳腺癌患者中的临床运用,分析乳腺癌患者上肢回流淋巴结的分布与转移特点。

方法

前瞻性选择2017年6月至2020年2月期间接受外科手术治疗的乳腺癌女性患者130例,所有患者均行ARM,且均为初次手术者。采用SPSS23.0进行统计学分析。术中上臂直径以(±s)表示,采用t检验;上肢回流淋巴结的转移单因素分析采用χ2检验分析,多因素分析采用Logistic回归分析,P<0.05差异有统计学意义。

结果

122例患者中501枚上肢回流淋巴结追踪成功,成功率为93.8%,A区和B区分别追踪327枚和106枚,共占83.1%,明显高于其他区域(P<0.05);而上肢回流淋巴结的行走方向以腋静脉、第二肋间臂神经、胸背神经血管束、背阔肌前缘以及前锯肌为界限,主要集中在腋静脉周围;单因素分析显示,患者腋窝淋巴情况、BMI指数、肿瘤分布位置、上臂直径与ARM技术上肢回流淋巴结转移有关(P<0.05),Logistic回归分析进一步表明,腋窝淋巴情况和肿瘤分布位置是ARM术上肢回流淋巴结转移的独立危险因素。

结论

ARM在乳腺癌手术中可成功定位淋巴结,通过了解淋巴分布位置和行走趋势,可提升淋巴系统保留的完整度,对降低术后淋巴水肿率,提高手术成功率有一定的意义。

Objective

To explore the clinical application of reverse axillary lymphography (RAL) for patients with breast cancer and to analyze the distribution and metastasis characteristics of upper extremity lymph nodes.

Methods

130 women with breast cancer who underwent primary surgical treatment between June 2017 and February 2020 were prospectively enrolled into the present study. All of them underwent reverse axillary lymphography. Statistical analysis were performed byusing SPSS23.0 software. The upper extremity diameter were expressed as (±s) and were analyzed by using t test. The single-factor analysis of upper extremity reflux lymph node metastasis was analyzed by using 2 test. Multivariate analysis of upper extremity reflux lymph node metastasis was performed by using Logistic regression analysis. A P value of <0.05 was considered as statistically significant difference.

Results

Among the 122 patients, 501 upper extremity reflux lymph nodes were successfully tracked, with A tracking success rate of 93.8%. In A and B regions, there were 327 and 106 tracked lymph nodes respectively, accounting for 83.1%, which was significantly higher than that in other regions (P<0.05). The direction of the upper extremity lymph nodes was along with the axillary vein, the second intercostal brachial nerve, the thoracic dorsal neurovascular bundle, the latissimus dorsi leading edge and the serratus anterior muscle, which were mainly around the axillary vein; Single factor analysis showed that the axillary lymph node status, BMI, tumor distribution location and upper extremity diameter of the patients were related to reflux lymph node metastasis (P<0.05), Logistic regression analysis further showed that the condition of axillary lymph nodes and tumor distribution were independent risk factors for RAL of upper limb reflux lymph node metastasis.

Conclusion

RAL provides a more precise location of upper limb reflux lymph node metastasis, through accurate analysis of the individual's physical condition and understanding of the lymphatic distribution and trend, the integrity of the lymphatic system could be improved, which has certain significance in reducing the rate of postoperative lymphedema and improving the success rate of surgery.

表1 130例乳腺癌患者术后上肢淋巴回流受阻一般资料
图1 ARM技术显影成功后淋巴分区及上肢回流淋巴结行走图[8][注:数字1~5分别代表前锯肌、腋静脉、第二肋间臂神经、胸背血管神经束、背阔肌前缘;红色线条①②③④描述上肢回流淋巴行走方向。]
表2 122例患者521枚淋巴结ARM术上肢回流淋巴结分布特征
表3 122例患者上肢回流淋巴结转移单因素分析
表4 122例患者上肢回流淋巴结转移的多因素分析
[1]
金洪飞.乳腺癌腋窝淋巴结清扫术中上肢淋巴结选择保留对淋巴水肿发生率的影响[J].湖南师范大学学报(医学版),2019,16(1):169-171.
[2]
王德华,吾建香,沈俊俊. 乳腔镜辅助腋窝淋巴结清扫手术对乳腺癌患者上肢功能及生活质量的影响[J]. 中华全科医学,2018,16(3):401-403.
[3]
Yoo T-K, Kang BJ, Kim SH, et al. Axillary lymph node dissection is not obligatory in breast cancer patients with biopsy-proven axillary lymph node metastasis[J] .Breast Cancer Res. Treat., 2020, 181(2): 403-409.
[4]
Jung J, Kim BH, Kim J, et al. Validating the ACOSOG Z0011 Trial Result: A Population-Based Study Using the SEER Database[J]. Cancers, 2020, 12(4): 950.
[5]
Chen XG, Chen XF, Yang JD, et al. Combining Dynamic Contrast-Enhanced Magnetic Resonance Imaging and Apparent Diffusion Coefficient Maps for a Radiomics Nomogram to Predict Pathological Complete Response to Neoadjuvant Chemotherapy in Breast Cancer Patients[J]. Journal of computer assisted tomography, 2020, 44(2): 275-283.
[6]
Shao Xuan, Sun Bo, Shen Yanwen. Axillary reverse mapping (ARM): where to go[J] .Breast Cancer, 2019, 26: 1-10.
[7]
朱倩男,夏添松,王水. 逆向腋淋巴显影技术在乳腺癌患者中的临床运用[J]. 南京医科大学学报:自然科学版,2017,37(12):1616-1618.
[8]
马小开.乳腺癌患者腋窝淋巴结转移规律及上肢淋巴流规律的临床研究[D]. 济南:山东大学,2019.
[9]
Beek MA, Gobardhan PD, Klompenhouwer EG, et al. A patient and assessor-blinded randomized controlled trial of axillary reverse mapping (ARM) in patients with early breast cancer[J] .Eur J Surg Oncol, 2020, 46: 59-64.
[10]
史发兰,季丽萍,贾爱群,等. 手法淋巴引流联合药物治疗乳腺癌术后淋巴水肿的效果研究[J]. 中国病案,2018,19(9):110-112.
[11]
Chumsri S, Sokol ES, Soyano-Muller AE, et al. Durable Complete Response With Immune Checkpoint Inhibitor in Breast Cancer With High Tumor Mutational Burden and APOBEC Signature[J]. J Natl Compr Canc Netw, 2020, 18(5): 517-521.
[12]
Tummel E, Ochoa D, Korourian S, et al. Does Axillary Reverse Mapping Prevent Lymphedema After Lymphadenectomy?[J] .Ann Surg, 2017, 265(5): 987-992.
[13]
Gandhi SJ, Satish C, Shanmuga PS, et al. Axillary reverse mapping using 99mTc-SC: a case illustration[J]. Clin Nucl Med, 2014, 39(10): e428-e430.
[14]
Faisal M, Sayed MG, Antonious K, et al. Prevention of lymphedema via axillary reverse mapping for arm lymph-node preservation following breast cancer surgery: a randomized controlled trial[J]. Patient Saf Surg, 2019, 13(1): 35.
[15]
Beek MA, Gobardhan PD, Schoenmaeckers EJP, et al. Axillary reverse mapping in axillary surgery for breast cancer: an update of the current status[J]. Breast Cancer Res Treat, 2016, 158(3): 421-432.
[1] 郏亚平, 曾书娥. 含鳞状细胞癌成分的乳腺化生性癌的超声与病理特征分析[J]. 中华医学超声杂志(电子版), 2023, 20(08): 844-848.
[2] 唐玮, 何融泉, 黄素宁. 深度学习在乳腺癌影像诊疗和预后预测中的应用[J]. 中华乳腺病杂志(电子版), 2023, 17(06): 323-328.
[3] 康夏, 田浩, 钱进, 高源, 缪洪明, 齐晓伟. 骨织素抑制破骨细胞分化改善肿瘤骨转移中骨溶解的机制研究[J]. 中华乳腺病杂志(电子版), 2023, 17(06): 329-339.
[4] 衣晓丽, 胡沙沙, 张彦. HER-2低表达对乳腺癌新辅助治疗疗效及预后的影响[J]. 中华乳腺病杂志(电子版), 2023, 17(06): 340-346.
[5] 施杰, 李云涛, 高海燕. 腋窝淋巴结阳性Luminal A型乳腺癌患者新辅助与辅助化疗的预后及影响因素分析[J]. 中华乳腺病杂志(电子版), 2023, 17(06): 353-361.
[6] 伍秋苑, 陈佩贤, 邓裕华, 何添成, 周丹. 肠道微生物在乳腺癌中的研究进展[J]. 中华乳腺病杂志(电子版), 2023, 17(06): 362-365.
[7] 谭巧, 苏小涵, 侯令密, 黎君彦, 邓世山. 乳腺髓样癌的诊治进展[J]. 中华乳腺病杂志(电子版), 2023, 17(06): 366-368.
[8] 周婉丽, 钱铮, 李喆. 槐耳在乳腺癌免疫治疗中的研究进展[J]. 中华乳腺病杂志(电子版), 2023, 17(06): 369-371.
[9] 熊倩, 罗凤. 乳腺癌患者术后康复现状与对策的研究进展[J]. 中华乳腺病杂志(电子版), 2023, 17(06): 372-374.
[10] 杨小菁, 姜瑞瑞, 石玉香, 王静静, 李长天. 乳腺孤立性纤维性肿瘤一例[J]. 中华乳腺病杂志(电子版), 2023, 17(06): 375-377.
[11] 冯雪园, 韩萌萌, 马宁. 乳腺原发上皮样血管内皮瘤一例[J]. 中华乳腺病杂志(电子版), 2023, 17(06): 378-380.
[12] 康一坤, 袁芃. 三阴性乳腺癌分子遗传学及临床特征研究进展[J]. 中华乳腺病杂志(电子版), 2023, 17(05): 290-293.
[13] 王雪菲, 海琳悦, 李立方, 肖春花. Luminal A型乳腺癌的内分泌治疗与化疗[J]. 中华乳腺病杂志(电子版), 2023, 17(05): 294-300.
[14] 晏晴艳, 雍晓梅, 罗洪, 杜敏. 成都地区老年转移性乳腺癌的预后及生存因素研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 636-638.
[15] 李智铭, 郭晨明, 庄晓晨, 候雪琴, 高军喜. 早期乳腺癌超声造影定性及定量指标的对比研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 639-643.
阅读次数
全文


摘要